Simple dialysis tweak could save thousands of lives

NCT ID NCT04079582

Ongoing Disease control Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding more magnesium to the fluid used during dialysis can help people with kidney failure live longer and have fewer heart-related hospital stays. Many dialysis patients have low magnesium, which can lead to muscle cramps and heart issues. The trial involves about 25,000 patients across many dialysis centers, comparing standard magnesium levels to higher ones. If it works, this cheap change could become the new standard of care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure kidney disorder kidney failure Muscle Cramp

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE KIDNEY DISEASE HEMODIALYSIS KIDNEY DISEASES

Contacts and locations

Locations

London Health Sciences Centre

London, Ontario, N6A5W9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.